Aflac Incorporated (NYSE:AFL) Shares Sold by Level Four Advisory Services LLC

Level Four Advisory Services LLC decreased its stake in Aflac Incorporated (NYSE:AFL) by 3.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 68,828 shares of the financial services provider’s stock after selling 2,599 shares during the quarter. Level Four Advisory Services LLC’s holdings in Aflac were worth $7,120,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in AFL. Hancock Whitney Corp increased its stake in Aflac by 6.2% during the 3rd quarter. Hancock Whitney Corp now owns 2,424 shares of the financial services provider’s stock worth $271,000 after buying an additional 142 shares in the last quarter. FMR LLC lifted its holdings in shares of Aflac by 4.0% in the 3rd quarter. FMR LLC now owns 1,202,104 shares of the financial services provider’s stock worth $134,395,000 after acquiring an additional 45,745 shares during the last quarter. Avestar Capital LLC grew its stake in shares of Aflac by 16.5% in the third quarter. Avestar Capital LLC now owns 2,937 shares of the financial services provider’s stock valued at $328,000 after buying an additional 415 shares in the last quarter. CreativeOne Wealth LLC purchased a new stake in Aflac during the 3rd quarter worth about $335,000. Finally, Public Sector Pension Investment Board grew its position in shares of Aflac by 0.3% during the third quarter. Public Sector Pension Investment Board now owns 87,995 shares of the financial services provider’s stock worth $9,838,000 after buying an additional 300 shares in the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Aflac

In other Aflac news, Director Charles D. Lake II sold 29,802 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the transaction, the director now owns 49,962 shares of the company’s stock, valued at $5,360,422.98. The trade was a 37.36 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the sale, the director now owns 25,393 shares of the company’s stock, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Aflac Stock Up 0.4 %

NYSE AFL opened at $110.87 on Friday. The business has a fifty day moving average price of $106.42 and a two-hundred day moving average price of $107.66. The stock has a market capitalization of $60.60 billion, a PE ratio of 11.55, a PEG ratio of 3.24 and a beta of 0.93. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. Aflac Incorporated has a fifty-two week low of $79.31 and a fifty-two week high of $115.50.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Equities analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. BMO Capital Markets started coverage on shares of Aflac in a report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price target for the company. Morgan Stanley upped their price target on shares of Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Friday, February 28th. Piper Sandler cut their target price on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Finally, Keefe, Bruyette & Woods reduced their price target on Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research report on Wednesday, February 12th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Aflac has a consensus rating of “Hold” and a consensus target price of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.